Background: Kidney cancer is the predominant form of malignancy of the kidney and accounts for approximately 3%-4% of all cancers. Renal cell cancer (RCC) represents more than 85% of kidney cancer. It has been reported that genetic factors may predispose individuals to RCC. This study evaluated the association between Acylphosphatase 2 (ACYP2) gene polymorphisms and RCC risk in the Han Chinese population. Methods: Twelve single-nucleotide polymorphisms (SNPs) in ACYP2 were genotyped using the Agena MassARRAY platform from 293 RCC patients and 495 controls. The Chi-squared test, genetic models, haplotype, and stratification analyses were used to evaluate the association between SNPs and the risk of RCC. The relative risk was estimated using the odds ratio (OR) and 95% confidence interval (CI).
| INTRODUCTION
Kidney cancer is the predominant form of malignancy of the kidney and accounts for approximately 3%-4% of all cancers (Torre et al., 2015) . An estimation of the worldwide incidence and mortality of 27 cancers reported that approximately 403,262 (2.2% of the total cases) new kidney cancer cases were diagnosed and 175,098 individuals died from kidney cancer (1.8 of the total cancer deaths) in 2018. Renal cell cancer (RCC) represents more than 85% of kidney cancer, and clear cell renal carcinoma is the most common type of RCC. Many epidemiological studies have found a number of predisposing conditions related to the development of RCC, such as cigarette smoking, alcohol intake, obesity, hypertension, and diabetes (Chow, Dong, & Devesa, 2010) . Although many subjects are exposed to these risk factors during their lifetime, only some individuals develop RCC, which suggests that genetic susceptibility may play a role in the etiology of RCC. Several studies indicate that the tumorigenesis of RCC involves a complex process determined by environmental and genetic factors as well as interactions between these factors (Semenza, Ziogas, Largent, Peel, & Anton-Culver, 2001) . Previous studies report that genetic polymorphisms in some genes are associated with a risk of RCC, such as IL-16 (Yang, Chen, Zhang, Sun, & Chen, 2015) and VDR .
ACYP2 is located on chromosome 2p16.2 and encodes the small cytosolic enzyme Acylphosphatase, which can hydrolyze the phosphoenzyme intermediates of different membrane pumps, particularly the Ca 2+ /Mg 2+ -ATPase from the sarcoplasmic reticulum of skeletal muscle. These enzymes can adjust the stability of the inner environment through calcium ion transport (Degl'Innocenti et al., 1999) . Previous studies show that ACYP2 overexpression promotes the differentiation of SH-SY5Y neuroblastoma cells (Cecchi et al., 2004) . ACYP2 is associated with colorectal cancer metastasis (Riley, Macnab, Farrell, & Cohn, 1997) . A genome-wide meta-analysis study demonstrated that a single-nucleotide polymorphism (SNP) (rs11125529) in ACYP2 is significantly associated with telomere length (Codd et al., 2013) . Interestingly, telomere length is associated with RCC risk and survival (Pal et al., 2015; Svenson, Ljungberg, & Roos, 2009) . Some studies indicated that the ACYP2 polymorphisms were associated with breast cancer , colorectal cancer (Fang et al., 2016) , lung cancer , gastric cancer , and liver cancer (Chen et al., 2017) . However, there are no previous reports examining the role of ACYP2 polymorphisms in the risk of RCC. The mRNA expression level of ACYP2 is significantly different between normal and kidney renal clear cell carcinoma samples based on major cancer stages, gender, and tumor grade from the UALCAN database, as shown in Figure 1 (http://ualcan.path.uab.edu/cgi-bin/ualcan-res. pl). ACYP2 low expression is associated with better survival in kidney renal clear cell carcinoma from the OncoLnc database, as shown in Figure 2 (http://www.oncol nc.org/). We hypothesized that ACYP2 polymorphisms are associated with the risk of RCC. To test this hypothesis, we conducted a casecontrol study to evaluate the association between 12 SNPs (rs6713088, rs12621038, rs1682111, rs843752, rs10439478, rs843645, rs11125529, rs12615793, rs843711, rs11896604, rs17045754, and rs843720) reported in previous studies (Chen et al., , 2017 Fang et al., 2016; He et al., 2016; Li et al., 2017; Liang et al., 2016; Liu et al., 2016; and the risk of RCC in the Chinese Han population.
| MATERIALS AND METHODS

| Study subjects
This study included 293 RCC patients and 495 unrelated healthy control subjects. The RCC patients were recruited from the First Affiliated Hospital of Xi'an Jiaotong University. The controls were randomly selected from individuals who requested general health examinations in the same hospital during the same period without any cancer history. All the individuals included in the study are ethnic Han Chinese with no genetic relationship, and their ancestors lived in the region for at least three generations. All the patients were newly diagnosed with histopathologically confirmed RCC. Patients who received chemotherapy or radiotherapy before surgery or had another F I G U R E 1 mRNA expression level of ACYP2 between normal and KIRC samples. KIRC, kidney renal clear cell carcinoma type of cancer were excluded from the study. All the patients were recruited without age, sex, or disease stage restrictions.
| Ethical approval
The study protocol was approved by the Medical Ethics Committee of the First Affiliated Hospital of Xi'an Jiaotong University. Each participant signed a written informed consent form prior to enrollment. This study conformed to the standards of the Declaration of Helsinki.
| DNA extraction
Peripheral venous blood samples were collected from both RCC patients and controls using vacutainer tubes containing EDTA. Genomic DNA was isolated from the blood samples using the GoldMag-Mini Whole Blood Genomic DNA Purification Kit (GoldMag. Co. Ltd.) following the manufacturer's instructions. DNA concentration and purity were evaluated using a spectrophotometer (NanoDrop 2000; Thermo Fisher Scientific).
| SNPs selection and genotyping
Twelve SNPs (rs6713088, rs12621038, rs1682111, rs843752, rs10439478, rs843645, rs11125529, rs12615793, rs843711, rs11896604, rs17045754, and rs843720) in ACYP2 screened in previous research Chen et al., 2017; Fang et al., 2016; He et al., 2016; Li et al., 2017; Liang et al., 2016; Liu et al., 2016; Zhang et al., 2016) at a minor allele frequency (MAF) > 5% in the global population were examined in our study. The amplification and extension SNP primers were designed using the Agena Bioscience Assay Design Suite V2.0 software (https ://agena cx.com/onlinetools/ ). The sequences of primers corresponding to each SNP are shown in Table 1 . These polymorphisms were genotyped using the Agena MassARRAY platform with iPLEX gold chemistry (Agena Bioscience) according to the standard protocol recommended by the manufacturer. Agena Bioscience TYPER version 4.0 software was used for data management and analysis.
| Statistical analysis
The Hardy-Weinberg equilibrium (HWE) of each SNP was assessed for the genotype frequencies in the control patients through an exact test. The allele frequencies between the RCC patients and controls were compared using a Chi-squared test, and the relative risk was estimated through an odds ratio (OR) and a 95% confidence interval (CI). Subsequently, we evaluated genetic polymorphisms of ACYP2 and RCC susceptibility under four genetic models (codominant, dominant, recessive, and log-additive) using the SNPStats software platform (https ://www.snpst ats.net/start.htm) (San Francisco et al., 2014; Sole, Guino, Valls, Iniesta, & Moreno, 2006) . Haploview software version 4.2 was used for the analysis of linkage disequilibrium (LD) and haplotype construction. The association between haplotypes and RCC risk was evaluated using PLINK software (Version 1.07). All statistical analyses were performed using Microsoft Excel (Microsoft Corp., Redmond, WA, USA) and the Statistical Package for the Social Sciences (SPSS) version 20.0 (SPSS Inc., Chicago, IL). We considered p values <.05 to be statistically significant and all statistical tests were two-sided.
| RESULTS
The characteristics of all study participants are presented in Table 2 . This study included 293 RCC patients (100 females and 193 males) and 495 (315 females and 180 males) healthy controls. The average ages of the cases and controls were F I G U R E 2 ACYP2 low expression is associated with better survival in kidney renal clear cell carcinoma Kaplan-Meier plots of overall survival: comparison of patients with high versus low expression of ACYP2 in kidney renal clear cell carcinoma patients (http://www.oncol nc.org/) 56.9 years and 54.5 years, respectively. The mean body mass index (BMI) of the cases and controls was 23.4 kg/m 2 and 23.1 kg/m 2 , respectively. There were significant differences in age, gender, smoking, and drinking between the RCC case and control groups (p < .05). To eliminate residual confounding effects, the variables of age, gender, and BMI were adjusted in the later logistic regression analysis.
The basic information of the selected SNPs and the associations with RCC risk are summarized in Table 3 , including band, position, role, alleles (A/B), HWE-P, and MAF (case and control). The genotype frequencies of rs843720 in the control group did not conform to HWE (p < .05); therefore, that polymorphism was excluded from further analysis. The frequency of the rs6713088 G allele in the cases (45.3%) was higher than that in the controls (39.7%) and had a significantly increased susceptibility to RCC (OR = 1.26, 95% CI: 1.03-1.53, p = .023). Meanwhile, the T allele of rs843711 was also associated with an increased risk of RCC (OR = 1.29, 95% CI: 1.06-1.57, p = .010).
Genetic model analyses found that rs843711 was associated with a 1.52-fold increase in the risk of RCC under the recessive model (OR = 1.52, 95% CI: 1.06-2.18, p = .025) and rs843711 was associated with a 1.31-fold increased risk of RCC under the log-additive model (OR = 1.31, 95% CI: 1.05-1.63, p = .017) after adjusting for age and gender, as shown in Table 4 .
Strong LD was observed between each pair of eight SNPs (rs1682111, rs843752, rs10439478, rs843645, rs11125529, rs12615793, rs843711, and rs11896604) in ACYP2, as shown in Figure 3 . The results of the association between the haplotypes and RCC risk are listed in Table 5 . We found that the haplotype "TTCTCGCC" was associated with a decreased risk of RCC after adjusting for age and gender (OR = 0.67, 95% CI: 0.48-0.94, p = .021).
In Table 6 , stratification analysis showed that rs6713088 also significantly increased the risk of RCC for those ≥ 55 years (OR = 1.33, 95% CI: 1.02-1.75, p = .037), smoking (OR = 1.59, 95% CI: 1.01-2.51, p = .047), and no drinking groups (OR = 1.42, 95% CI: 1.06-1.88, p = .017). We also found that rs843711 significantly increased the risk of RCC for ages ≥ 55 years (OR = 1.38, 95% CI: 1.05-1.80, p = .019), no smoking (OR = 1.47, 95% CI: 1.09-1.99, p = .012), smoking (OR = 1.90, 95% CI: 1.21-3.00, p = .005), no drinking (OR = 1.53, 95% CI: 1.15-2.02, p = .003), and I/II stage (OR = 1.29, 95% CI: 1.04-1.60, p = .023) groups.
| DISCUSSION
This study evaluated the association between ACYP2 polymorphisms and the risk of RCC in the Han Chinese population. Our results showed that rs6713088 and rs843711 were associated with increased risk of RCC and the haplotype "TTCTCGCC" (rs1682111, rs843752, rs10439478, rs843645, rs11125529, rs12615793, rs843711, and rs11896604) had a statistically significant reduced susceptibility to RCC. In addition, stratification analysis found that rs6713088 and rs843711 significantly increased the risk of RCC. The pathogenesis of RCC is not clear. Previous reports indicate that ACYP2 can adjust the stability of the inner environment of Ca 2+ . Ca 2+ homeostasis is the first sign of apoptosis (Sawant, Dasgupta, Lavhale, & Sitasawad, 2016 ) that can regulate cell survival and death (Hajnoczky, Davies, & Madesh, 2003) . Cancer cells can prevent calcium flow by reducing the expression of Ca 2+ channels, gaining resistance to long-term endoplasmic reticulum calcium deficiency, and downregulating the mitochondrial calcium unidirectional transporter, which prevents apoptosis (Pinton, Giorgi, Siviero, Zecchini, & Rizzuto, 2008) . In addition, ACYP2 is associated with telomere length, which is crucial for maintaining chromosome integrity and genomic stability (Blackburn, 2010) , but a critically short telomere length can initiate the process of carcinogenesis (Cheung & Deng, 2008) . We know that apoptosis plays an important role in the development of tumors. Therefore, ACYP2 mutations may affect telomere length and regulate apoptosis as well as further promote tumorigenesis.
Although rs11125529 is significantly associated with telomere length (Codd et al., 2013) , no significant association was found between rs11125529 and RCC risk in this study. The ACYP2 polymorphisms were previously reported to be associated with cancers risk, as shown in Table 7 . Our results showed that rs6713088 was significantly associated with an increased risk of RCC. Other studies found that rs6713088 was also associated with increased risk of colorectal cancer (OR = 1.75, 95% CI: 1.03-2.97, p = .038) (Fang et al., 2016) , gastric cancer (OR = 1.30, 95% CI: 1.03-1.64, p = .024) , and liver cancer (OR = 1.27, 95% CI: 1.07-1.52, p = .007) (Chen et al., 2017) . In addition, rs843711 also exhibited an increased risk of RCC both under the recessive and log-additive model. Previous association studies observed that rs843711 was associated with an increased risk of colorectal cancer (OR = 1.38, 95% CI: 1.08-1.75, p = .009) (Fang et al., 2016) , gastric cancer (OR = 1.40, 95% CI: 1.12-1.76, p = .004) , and liver cancer (OR = 1.29, 95% CI: 1.09-1.54, p = .004) (Chen et al., 2017) . The SNPs rs12621038, rs1682111, rs17045754, rs11896604, rs843706, and rs11125529 were previously reported to be associated with the risk of breast cancer Zhang et al., 2016) . The SNPs rs1682111, rs11896604, and rs843720 were found to be associated with lung cancer risk . However, the association of rs6713088, rs843711, and other SNP loci with susceptibility to RCC had not been reported. Therefore, the association between the polymorphisms in the ACYP2 and the risk of RCC should be verified in a large sample. In addition, the incidence of RCC increases with age (Chow & Devesa, 2008) . A previous study found that smoking may increase RCC risk through chronic tissue hypoxia due to carbon monoxide exposure (Sharifi & Farrar, 2006) . In RCC, peripheral blood lymphocytes have a higher level of DNA damage induced by a tobacco-specific N-nitrosamine (Clague et al., 2009) . A meta-analysis study (Bellocco et al., 2012) reported that alcohol drinking has a negative association with the risk of RCC through the effects of alcohol on insulin sensitivity (Kiechl et al., 1996) . Stratification analysis also found that rs6713088 and rs843711 significantly increased the risk of RCC.
Several limitations should not be ignored in this study. First, the sample size is relatively small. Second, we did not measure telomere length or assess the association between telomere length and the risk of RCC. Third, we also did not perform functional analyses. Therefore, further study will be needed to verify the results with a larger sample size and more comprehensive analyses.
In summary, our results confirmed that rs6713088 and rs843711 were connected to a significantly increased risk of RCC, but the haplotype "TTCTCGCC" was associated with a decreased risk of RCC in the Han Chinese population. Our results provide a theoretical basis for further study of the association between telomere length-related gene (ACYP2) and the risk of RCC. 
